...
首页> 外文期刊>Vaccine >Production of high titer attenuated poliovirus strains on the serum-free PER.C6 (R) cell culture platform for the generation of safe and affordable next generation IPV
【24h】

Production of high titer attenuated poliovirus strains on the serum-free PER.C6 (R) cell culture platform for the generation of safe and affordable next generation IPV

机译:在无血清的PER.C6(R)细胞培养平台上生产高滴度的脊髓灰质炎病毒减毒株,用于生成安全且负担得起的下一代IPV

获取原文
获取原文并翻译 | 示例
           

摘要

Background: As poliovirus eradication draws closer, alternative Inactivated Poliovirus Vaccines (IPV) are needed to overcome the risks associated with continued use of the Oral Poliovirus Vaccine and of neurovirulent strains used during manufacture of conventional (c) IPV. We have previously demonstrated the susceptibility of the PER.C6 (R) cell line to cIPV strains; here we investigated the suspension cell culture platform for growth of attenuated poliovirus strains.
机译:背景:随着消灭脊髓灰质炎病毒的日益临近,需要使用替代的灭活脊髓灰质炎疫苗(IPV)来克服与持续使用口服脊髓灰质炎病毒疫苗和在常规(c)IPV生产过程中使用的神经毒性毒株相关的风险。先前我们已经证明PER.C6(R)细胞系对cIPV株具有敏感性。在这里,我们研究了减毒脊髓灰质炎病毒株生长的悬浮细胞培养平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号